Results may vary. Actual vial appearance, contents, and dosage may vary and is based on your prescription. View full disclaimer in footer.*
Programs starting at $379/month.
Includes provider consult, prescription, and shipping.
A physician-prescribed, compounded GLP-1 program designed for sustainable weight loss without daily injections.
Semaglutide is a GLP-1 receptor agonist — a class of medications originally developed for type 2 diabetes and now widely used for weight management. It works by signaling fullness, slowing gastric emptying, and reducing food noise and cravings. Most clinical research has been done on injectable forms. Compounded sublingual semaglutide delivers the same active molecule under the tongue, where it is absorbed through the oral mucosa. For patients who don't tolerate injections or prefer a daily oral dose, sublingual is a practical alternative — when prescribed and monitored by a clinician.
*Price shown applies to 6-Month plan paid upfront or with buy now, pay later programs. Actual price will depend on product and plan prescribed.
**The FDA does not review or approve any compounded medications for safety or effectiveness.
Compounded medications are not FDA-approved drugs. They are prepared by licensed compounding pharmacies based on a clinician's prescription for an individual patient. Individual results vary. A medical evaluation is required to determine if this therapy is appropriate for you. Some uses discussed may be considered off-label.